A study has pointed out that radioactive iodine (RAI), thyroid-stimulating hormone (TSH) levels, luteinizing hormone (LH) and follicle-stimulating hormone (FSH) homology, immune system decline, and genetic variation are associated with poor prognosis in thyroid cancer patients of advanced age (23). This evidence concerns the gene PLOD1 and thyroid cancer.